
Marianne P. Allen
Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1818, 1812, 1645, 1805, 1631, 1647 |
| Total Applications | 2168 |
| Issued Applications | 1046 |
| Pending Applications | 251 |
| Abandoned Applications | 885 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6804937
[patent_doc_number] => 20030232331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Novel proteins and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 10/005041
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84936
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232331.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005041 | Novel proteins and nucleic acids encoding same | Dec 3, 2001 | Abandoned |
Array
(
[id] => 6157577
[patent_doc_number] => 20020146724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Biopolymer sequence comparison'
[patent_app_type] => new
[patent_app_number] => 10/006492
[patent_app_country] => US
[patent_app_date] => 2001-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14507
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146724.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006492 | Biopolymer sequence comparison | Dec 2, 2001 | Issued |
Array
(
[id] => 5859052
[patent_doc_number] => 20020123104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Human slit polypeptide and polynucleotides encoding same'
[patent_app_type] => new
[patent_app_number] => 10/011064
[patent_app_country] => US
[patent_app_date] => 2001-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11717
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123104.pdf
[firstpage_image] =>[orig_patent_app_number] => 10011064
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/011064 | Human slit polypeptide and polynucleotides encoding same | Dec 2, 2001 | Abandoned |
Array
(
[id] => 6366501
[patent_doc_number] => 20020059158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Determination of population safe dosage levels of pharmaceutically active substances'
[patent_app_type] => new
[patent_app_number] => 09/998189
[patent_app_country] => US
[patent_app_date] => 2001-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7292
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20020059158.pdf
[firstpage_image] =>[orig_patent_app_number] => 09998189
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/998189 | Determination of population safe dosage levels of pharmaceutically active substances | Dec 2, 2001 | Abandoned |
Array
(
[id] => 7306895
[patent_doc_number] => 20040116682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Nucleic acid molecules and other molecules associated with the carbon assimilation pathway'
[patent_app_type] => new
[patent_app_number] => 09/987899
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 152859
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116682.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987899
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987899 | Nucleic acid molecules and other molecules associated with the carbon assimilation pathway | Nov 15, 2001 | Abandoned |
Array
(
[id] => 6448443
[patent_doc_number] => 20020129004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Software enabled wizards'
[patent_app_type] => new
[patent_app_number] => 10/039482
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 74
[patent_no_of_words] => 19865
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20020129004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10039482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/039482 | Software enabled wizards | Nov 8, 2001 | Abandoned |
| 10/004292 | map | Oct 28, 2001 | Abandoned |
Array
(
[id] => 6048592
[patent_doc_number] => 20020169108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production'
[patent_app_type] => new
[patent_app_number] => 10/045534
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 33565
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169108.pdf
[firstpage_image] =>[orig_patent_app_number] => 10045534
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/045534 | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production | Oct 23, 2001 | Abandoned |
Array
(
[id] => 4979387
[patent_doc_number] => 20070220622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Nucleic acid molecules and other molecules associated with the cytokinin pathway'
[patent_app_type] => utility
[patent_app_number] => 09/976054
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73558
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20070220622.pdf
[firstpage_image] =>[orig_patent_app_number] => 09976054
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/976054 | Nucleic acid molecules and other molecules associated with the cytokinin pathway | Oct 14, 2001 | Issued |
Array
(
[id] => 6049026
[patent_doc_number] => 20020169297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Genetic insulator for preventing influence by another gene promoter'
[patent_app_type] => new
[patent_app_number] => 09/973945
[patent_app_country] => US
[patent_app_date] => 2001-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10319
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169297.pdf
[firstpage_image] =>[orig_patent_app_number] => 09973945
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/973945 | Genetic insulator for preventing influence by another gene promoter | Oct 10, 2001 | Abandoned |
Array
(
[id] => 949769
[patent_doc_number] => 06963805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-08
[patent_title] => 'Methods for identifying the evolutionarily conserved sequences'
[patent_app_type] => utility
[patent_app_number] => 09/972595
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20026
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/963/06963805.pdf
[firstpage_image] =>[orig_patent_app_number] => 09972595
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/972595 | Methods for identifying the evolutionarily conserved sequences | Oct 4, 2001 | Issued |
Array
(
[id] => 6080966
[patent_doc_number] => 20020081750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Drug evaluation operating principles'
[patent_app_type] => new
[patent_app_number] => 09/956094
[patent_app_country] => US
[patent_app_date] => 2001-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8412
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081750.pdf
[firstpage_image] =>[orig_patent_app_number] => 09956094
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/956094 | Drug evaluation operating principles | Sep 19, 2001 | Abandoned |
Array
(
[id] => 6157682
[patent_doc_number] => 20020146751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'fabF'
[patent_app_type] => new
[patent_app_number] => 09/956398
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16101
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146751.pdf
[firstpage_image] =>[orig_patent_app_number] => 09956398
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/956398 | fabF | Sep 18, 2001 | Abandoned |
Array
(
[id] => 6756542
[patent_doc_number] => 20030004319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Mammalian growth factor'
[patent_app_type] => new
[patent_app_number] => 09/940601
[patent_app_country] => US
[patent_app_date] => 2001-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10085
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004319.pdf
[firstpage_image] =>[orig_patent_app_number] => 09940601
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/940601 | Mammalian growth factor | Aug 26, 2001 | Abandoned |
Array
(
[id] => 6157716
[patent_doc_number] => 20020146764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Expression using fused genes providing for protein product'
[patent_app_type] => new
[patent_app_number] => 09/931216
[patent_app_country] => US
[patent_app_date] => 2001-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9841
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146764.pdf
[firstpage_image] =>[orig_patent_app_number] => 09931216
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/931216 | Expression using fused genes providing for protein product | Aug 15, 2001 | Abandoned |
Array
(
[id] => 5921743
[patent_doc_number] => 20020115144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Compositions for the diagnosis and treatment of chediak-higashi syndrome'
[patent_app_type] => new
[patent_app_number] => 09/927668
[patent_app_country] => US
[patent_app_date] => 2001-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 91
[patent_no_of_words] => 24295
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115144.pdf
[firstpage_image] =>[orig_patent_app_number] => 09927668
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/927668 | Compositions for the diagnosis and treatment of chediak-higashi syndrome | Aug 9, 2001 | Abandoned |
Array
(
[id] => 7394039
[patent_doc_number] => 20040038341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Chimeric human-type vascular endothelial cell growth factor'
[patent_app_type] => new
[patent_app_number] => 10/343825
[patent_app_country] => US
[patent_app_date] => 2003-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9274
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038341.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343825
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343825 | Chimeric human-type vascular endothelial cell growth factor | Aug 8, 2001 | Issued |
| 09/890689 | Cdna sequence of an iteractor fancip1 of the fanconi anaemia protein of complementation group a | Aug 1, 2001 | Abandoned |
Array
(
[id] => 6869855
[patent_doc_number] => 20030082544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Methods and systems for validating detection assays, developing in-vitro diagnostic DNA or RNA analysis products, and increasing revenue and/or profit margins from in-vitro diagnostic DNA or RNA analysis assays'
[patent_app_type] => new
[patent_app_number] => 09/915063
[patent_app_country] => US
[patent_app_date] => 2001-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 44688
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082544.pdf
[firstpage_image] =>[orig_patent_app_number] => 09915063
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/915063 | Methods and systems for validating detection assays, developing in-vitro diagnostic DNA or RNA analysis products, and increasing revenue and/or profit margins from in-vitro diagnostic DNA or RNA analysis assays | Jul 24, 2001 | Abandoned |
Array
(
[id] => 1137576
[patent_doc_number] => 06780600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-24
[patent_title] => 'Synaptic activation protein compositions and method'
[patent_app_type] => B2
[patent_app_number] => 09/910706
[patent_app_country] => US
[patent_app_date] => 2001-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 35
[patent_no_of_words] => 12339
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/780/06780600.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910706
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910706 | Synaptic activation protein compositions and method | Jul 19, 2001 | Issued |